GENinCode UK Ltd. (GB:GENI) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
GENinCode has partnered with Genesupport SA to provide the ROCA Test for ovarian cancer surveillance across Switzerland, making it accessible to over 11,000 women at high risk. This collaboration aims to improve early detection and treatment outcomes, leveraging the ROCA Test’s proven accuracy and extensive clinical evaluation. The partnership is set to enhance preventive healthcare options for women with genetic predispositions to ovarian cancer.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.